Dollars for Docs lists the following 10 drugs for which companies paid the most in payments to physicians last year:
1. Xarelto (a blood thinner) — $28.4 million
2. Humira (rheumatoid arthritis drug) — $24.9 million
3. Invokana (drug for diabetes) — $20.9 million
4. Viekira (hepatitis C drug) — $19.2 million
5. Eliquis (blood thinner) — $18.8 million
6. Bydureon (diabetes drug) — $18.5 million
7. Androgel (testosterone drug)— $15.3 million
8. Synthroid (thyroid drug)—$14.7 million
9. Lupron (synthetic hormone) — $14.3 million
10. Victoza (diabetes drug)— $11.9 million
More articles on quality & infection control:
The Joint Commission addresses confusion surrounding provider text messaging: 5 things to know
Global disposable syringes market to surge to $9.9B by 2024: 4 points
Study: ’32k fewer patients would die every year if male physicians could achieve the same outcomes as female physicians’
